Clark Capital Management Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Clark Capital Management Group’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-72,459	Closed	-$4.22M	–	325
2015 Q2	$4.22M	Sell	72,459 -6,153	-8%	-$359K	0.39%	76
2015 Q1	$4.52M	Buy	+78,612	New	+$4.3M	0.41%	75
2014 Q2	–	Sell	-187,650	Closed	-$7.92M	–	342
2014 Q1	$7.92M	Buy	187,650 +64,608	+53%	+$2.71M	0.68%	36
2013 Q4	$4.84M	Buy	+123,042	New	+$4.62M	0.4%	71
2013 Q3	–	Sell	-184,641	Closed	-$6.13M	–	352
2013 Q2	$6.13M	Buy	+184,641	New	+$6.13M	0.56%	42

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

BWM

Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Clark Capital Management Group's IHE Position: Q3 2015 in Review

Clark Capital Management Group sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2015, closing a stake of 72,459 shares — an estimated $4.22M sold.

Clark Capital Management Group first reported a position in IHE in Q2 2013 and held it in 5 quarters. The position peaked at $7.92M in Q1 2014. 102 funds tracked by Wall St. Rank hold IHE as of Q3 2015.

Clark Capital Management Group reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Clark Capital Management Group sold 72,459 iShares US Pharmaceuticals ETF shares in Q3 2015, an estimated $4.22M.
Clark Capital Management Group first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 5 quarters.
Clark Capital Management Group's iShares US Pharmaceuticals ETF position peaked at $7.92M in Q1 2014.
102 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2015.

Based on Clark Capital Management Group's 13F filing for Q3 2015, filed 3 Nov 2015.